Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-01-15, Stock:PFE, The news for the past five days is as follows:
2020-01-08: NEWS1: Among Top 5 Pharma Companies, Pfizer Was the Worst Performer in 2019.NEWS2: 3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2020.
2020-01-09: NEWS1: Pfizer Stock Has No Momentum in Its Business or on the Charts.NEWS2: Viatris Will Be the New Kid in Generic Drugs. Don’t Expect the Stock to Surge, Analyst Says..NEWS3: Waltham's Amag Pharma replacing CEO, cutting two products.NEWS4: Merck's Keytruda Gets FDA Nod for High-Risk Bladder Cancer.NEWS5: eFFECTOR Enters Into Agreement with Pfizer Inc. to Develop Novel First-in-Class Inhibitors of eIF4E to Treat Multiple Cancer Types.NEWS6: Top Picks 2020- Pfizer PFE.
2020-01-10: NEWS1: Eli Lilly Made a Deal for Dermira. The Biotech’s Stock Price Shows Investors Expect More..NEWS2: Dow Jones Today: Stocks Pinched by Jobs Disappointment.NEWS3: Stock Market Gives Back Early Gains After Weakish Jobs Data; These Chinese Growth Stocks Continue To Rise.NEWS4: California may become first state to sell its own prescription drugs.NEWS5: Pfizer Offers a Strong Combination of Growth and Income.NEWS6: Dogs of the Dow 2020: 10 Dividend Stocks to Watch.NEWS7: All Bets Are Off for Amarin Stock.
2020-01-13: NEWS1: Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know.NEWS2: Top Pharmaceutical Stocks for Q1 2020.NEWS3: Is Pfizer (PFE) Stock Outpacing Its Medical Peers This Year?.NEWS4: Glaxo Files Marketing Application for Fostemsavir in Europe.NEWS5: In time for biotech's biggest conference, Union Square costs climb.NEWS6: Nektar Up 25% as Bristol-Myers Expands Bempeg Collaboration.NEWS7: Benzinga Pro's Top 5 Stocks To Watch For Mon., Jan. 13, 2020: WCC, LULU, XLF, TEAM, BIIB.NEWS8: Biogen to buy from Pfizer an asset to develop into potential Alzheimer's, Parkinson's treatments.NEWS9: Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimer’s Disease and Parkinson’s Disease from Pfizer Inc..NEWS10: Axsome Therapeutics Enters into Exclusive License Agreement with Pfizer Inc. for Pfizer’s Reboxetine Clinical and Nonclinical Data and for New Phase 3 Esreboxetine Product Candidate.
2020-01-14: NEWS1: Dow Jones Today: JPMorgan Gives Dow a Lift as Stocks Falter Near Highs.NEWS2: Pharmacia Corporation (Old Monsanto) -- Moody's announces completion of a periodic review of ratings of Pfizer Inc..NEWS3: JPMorgan Chase, Walgreens Boots share gains contribute to Dow's nearly 75-point climb.NEWS4: 7 Dividend ETFs That Offer Growth in 2020.NEWS5: Biogen Acquires Early-Stage CNS Drug From Pfizer for $75M.NEWS6: Insilico enters into research collaboration with Pfizer Inc. to explore novel data and artificial intelligence system for potential therapeutic targets.

Answer: Rise